Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2138]

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment, research shows

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment...

Drug triggers immune cells to attack prostate cancer

Drug triggers immune cells to attack prostate cancer

Treatment without hormone blockers improves outcomes in solitary prostate cancer metastases

Treatment without hormone blockers improves outcomes in solitary prostate cancer metastases

Magnetosome-like structure with high tumour tissue penetration efficiency constructed

Magnetosome-like structure with high tumour tissue penetration efficiency constructed

Sugar molecules as a target in cancer therapy

Sugar molecules as a target in cancer therapy

Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated with systemic drug therapies

Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated...

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

Advanced nanoparticles provide new weapon to fight difficult cancers

Advanced nanoparticles provide new weapon to fight difficult cancers

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Metastasis-directed radiation therapy plus hormone therapy improves progression-free survival for men with advanced prostate cancer

Metastasis-directed radiation therapy plus hormone therapy improves progression-free survival for men with...

More from ecancer